Abstract
Telomerase is activated in most tumors, but suppressed in normal human somatic cells. Current evidence indicates that telomerase reactivation is a critical step in carcinogenesis, with a close relationship to apoptosis. The goal of this study was to investigate the levels and relationship of telomerase activity to apoptosis and its impact on the survival of Egyptian adult acute lymphoblastic leukemia patients. Telomerase activity was quantified by polymerase chain reaction (PCR) and detected by enzyme-linked immunosorbent assay (ELISA), while apoptosis was measured at the single-cell level by fluorescence in situ detection using flow cytometry in 15 control subjects and 40 acute lymphoblastic leukemia (ALL) patients at presentation. Telomerase activity in ALL patients was negatively correlated to apoptosis [percent and mean fluorescence intensity (MFI)] (p < 0.001 for percent and p < 0.001 for MFI) and to the 4-year survival rate (p < 0.05), to which apoptosis (percent and MFI) was consequently positively correlated (p < 0.001 for percent and p < 0.05 for MFI). For telomerase, the highest positive predictive value (PPV) for mortality (93.3%) was at a cut-off value of 13 amol/ml, while those for apoptosis (85% for percent of apoptotic cells and 90.9% for MFI) were at a cut-off of 8% and 0.19 MFI. This makes the measurement of telomerase activity in ALL patients a potential tool to predict disease with unfavorable outcome and a candidate tumor marker.
Similar content being viewed by others
References
Blackburn EH (1991) Structure and function of telomeres. Nature 350:569–573
Blackburn EH (2000) The end of the (DNA) line. Nat Struct Biol 7:847–850
Broccoli D, Smogorzewska A, Chong L, de Lange T (1997) Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet 17(2):231–235
El-Daly H, Kull M, Zimmermann S, Pantic M, Waller CF, Martens UM (2005) Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532. Blood 105:1742–1749
Granger MP, Wright WE, Shay JW (2002) Telomerase in cancer and aging. Crit Rev Oncol Hematol 41:29–40
Hahn WC (2003) Role of telomeres and telomerase in the pathogenesis of human cancer. J Clin Oncol 21(10):2034–2043
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70
Liu WJ, Jiang JF, Xiao D, Ding Y (2002) Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis. Biochem Pharmacol 64(2):1677–1687
Misawa M, Tauchi T, Sashida G, Nakajima H, Abe K, Ohyashiki JH, Ohyashiki K (2002) Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells. Int J Oncol 21:1087–1092
Misiti S, Nanni S, Fontemaggi G, Cong YS, Wen J, Hirte HW, Piaggio G, Sacchi A, Pontecorvi A, Bacchetti S, Farsetti A (2000) Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cell. Mol Cell Biol 20:3764–3771
Mondello C, Scovassi AI (2004) Telomeres, telomerase, and apoptosis. Biochem Cell Biol 82(4):498–507
Mrózek K, Heerema NA, Bloomfield CD (2004) Cytogenetics in acute leukemia. Blood Rev 18:115–136
Nakajima A, Tawchi T, Sashida G, Sumi M, Abe K, Ohyashiki K (2003) Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy. Leukemia 17:560–567
Nowak J, Januszkiewicz D, Lewandowski K, Nowicka-Kujawska K, Pernak M, Rembowska J, Nowak T, Wysocki J (2003) Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients. Eur J Gastroenterol Hepatol 15(1):75–80
Ohyashiki JH, Shashida G, Tauchi T, Ohyashiki K (2002) Telomeres and telomerase in hematologic neoplasia. Oncogene 21:680–687
Ren JG, Xia HL, Tian YM, Just T, Cai GP, Dai YR (2001) Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung fibroblasts. FEBS Lett 488:133–138
Ross JS, Schenkein DP, Pietrusko R, Rolfe M, Linette GP, Stec J, Stagliano NE, Ginsburg GS, Symmans WF, Pusztai L, Hortobagyi GN (2004) Targeted therapies for cancer 2004. Am J Clin Pathol 122(4):598–609
Schuler D, Szende B (2004) Apoptosis in acute leukemia. Leuk Res 28:661–666
Shammas A, Liu X, Gavory G, Raney KD, Balasubramanion S, Shmookler RRJ (2004) Targeting the single-strand G-rich overhang of telomeres with PNA inhibits cell growth and induces apoptosis of human immortal cells. Exp Cell Res 295(1):204–214
Shay JW, Wright WE (2000) Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol 1:72–76
Shay JW, Zou Y, Hiyama E, Wright WE (2001) Telomerase and cancer. Hum Mol Genet 10(7):677–685
Uchida N, Otsuka T, Arima F, Shigematsu H, Fukuyama T, Maeda M, Sugio Y, Itoh Y, Niho Y (1999) Correlation of telomerase activity with development and progression of adult T-cell leukemia. Leuk Res 23:311–316
Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18:173–179
Xu, Gruber A, Peterson C, Pisa P (1998) Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia. Br J Haematol 102:1367–1375
Yajima Y, Noma H, Furuya Y, Nomura T, Yamauchi T, Kasahara K, Hatada K, Takano M (2004) Quantification of telomerase activity of regions unstained with iodine solution that surround oral squamous cell carcinoma. Oral Oncol 40(3):314–320
Zendehrokh N, Dejmek A (2005) Telomere repeat amplification protocol (TRAP) in situ reveals telomerase activity in three cell types in effusions: malignant cells, proliferative mesothelial cells, and lymphocytes. Mod Pathol 18:189–196
Zhang J-X, Zhang Z-K, Sheng H-P, Tsao S-W, Loh T-T (2000) Telomerase activity is not related to apoptosis in leukemic cell lines. Life Sci 66(18):1713–1723
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Asfour, I.A., Fayek, M.H., El-kourashy, S.AE.A. et al. Correlation of telomerase activity to apoptosis and survival in adult acute lymphoblastic leukemia: an Egyptian single-center study. Ann Hematol 87, 213–221 (2008). https://doi.org/10.1007/s00277-007-0395-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-007-0395-2